China Universal Asset Management Co., Ltd. Neurocrine Biosciences Inc Transaction History

China Universal Asset Management Co., Ltd.

$1.17 Billion
Q3 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,385 shares of NBIX stock, worth $2.52 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

17,385

Previous 19,877 12.54%

Holding current value

$2.52 Million

Previous $2.5 Million 2.32%

% of portfolio

0.21%

Previous 0.24%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$123.98 - $146.67 $308,958 - $365,501	-2,492 Reduced 12.54%	17,385 $2.44 Million
Q2 2025 Aug 28, 2025	SELL	$87.54 - $128.18 $10,679 - $15,637	-122 Reduced 0.61%	19,877 $2.5 Million
Q1 2025 Apr 29, 2025	SELL	$107.22 - $153.29 $157,506 - $225,183	-1,469 Reduced 6.84%	19,999 $2.21 Million
Q4 2024 Jan 23, 2025	BUY	$111.62 - $139.44 $228,486 - $285,433	2,047 Added 10.54%	21,468 $2.93 Million
Q3 2024 Oct 25, 2024	BUY	$114.58 - $153.15 $870,464 - $1.16 Million	7,597 Added 64.25%	19,421 $2.24 Million

Q2 2024 Jul 19, 2024	SELL	$130.86 - $143.19 $958,418 - $1.05 Million	-7,324 Reduced 38.25%	11,824 $1.63 Million
Q1 2024 Apr 29, 2024	BUY	$130.4 - $143.74 $1.02 Million - $1.12 Million	7,784 Added 68.5%	19,148 $2.64 Million
Q4 2023 May 21, 2024	SELL	$106.07 - $132.76 $825,648 - $1.03 Million	-7,784 Reduced 40.65%	11,364 $1.5 Million
Q4 2023 Jan 23, 2024	BUY	$106.07 - $132.76 $939,780 - $1.18 Million	8,860 Added 353.83%	11,364 $1.5 Million
Q3 2023 May 21, 2024	BUY	$94.02 - $117.1 $115,174 - $143,447	1,225 Added 95.78%	2,504 $281,000
Q3 2023 Oct 30, 2023	BUY	$94.02 - $117.1 $115,174 - $143,447	1,225 Added 95.78%	2,504 $282,000
Q2 2023 May 21, 2024	SELL	$89.53 - $104.87 $2,685 - $3,146	-30 Reduced 2.29%	1,279 $120,000
Q2 2023 Jul 27, 2023	SELL	$89.53 - $104.87 $2,685 - $3,146	-30 Reduced 2.29%	1,279 $121,000
Q1 2023 May 21, 2024	BUY	$94.11 - $123.02 $31,244 - $40,842	332 Added 33.98%	1,309 $132,000
Q1 2023 Apr 27, 2023	BUY	$94.11 - $123.02 $31,244 - $40,842	332 Added 33.98%	1,309 $132,000
Q4 2022 May 21, 2024	SELL	$106.72 - $127.06 $1.94 Million - $2.31 Million	-18,171 Reduced 94.9%	977 $116,000
Q4 2022 Jan 31, 2023	BUY	$106.72 - $127.06 $8,644 - $10,291	81 Added 9.04%	977 $117,000
Q3 2022 Oct 21, 2022	BUY	$92.03 - $107.81 $82,458 - $96,597	896 New	896 $95,000

Others Institutions Holding NBIX

# of Institutions

724

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Neurocrine Biosciences Inc Transaction History